Elevance Health insiders are buying in: Marks Gilbert Lynn’s zero‑price stock grant shows confidence amid analyst‑raised targets and rising share price.
Elevance Health CFO sells 4,161 shares after exercising restricted shares, showing routine liquidity while maintaining confidence in the company’s growth prospects.
Elevance Health insider Readnour Robin Shane quietly sells 1% of shares via Rule 10b‑5‑1, signalling strategic portfolio rebalancing without diluting EPS.